2nd Quarter - Report — ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY (2017)

Firm

ACADEMY OF MANAGED CARE PHARMACY

Client

ACADEMY OF MANAGED CARE PHARMACY

Income

—

Expenses

$70,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Comments submitted advocating for transformation and modernization of the Medicare Part D program.

Lobbyist	Covered position, as disclosed
REGINIA GRAYSON BENJAMIN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Letters of support for the CREATES Act (H.R. 2212 and S. 974), the FAST Act (H.R. 2051) and the Pharmaceutical Information Exchange Act(H.R. 2026). Comments to FDA on biosimilars and interchangeability,

Lobbyist	Covered position, as disclosed
REGINIA GRAYSON BENJAMIN	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 974 (115th), H.R. 2026 (115th), H.R. 2212 (115th), H.R. 2051 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.

What was lobbied

Medicare/Medicaid MMM

Pharmacy PHA